English | Español
Patient Daily | Jan 19, 2026

Moderna reports progress on cost-cutting but faces questions over break-even timeline
Patient Daily | Jan 19, 2026

Aurora Therapeutics launches with $16M seed round aiming at scalable personalized gene therapy
Patient Daily | Jan 19, 2026

FDA removes special risk program for CAR T therapies amid calls for better side effect management
Patient Daily | Jan 19, 2026

Early-stage biotech funding drops as investors shift focus to late-stage assets
Patient Daily | Jan 19, 2026

How businesses can link digital campaigns with in-store revenue
Patient Daily | Jan 19, 2026

Veradermics and Eikon Therapeutics announce plans for initial public offerings
Patient Daily | Jan 19, 2026

Novartis enters global Alzheimer’s partnership with SciNeuro Pharmaceuticals
Patient Daily | Jan 19, 2026

Flagship CEO warns US risks falling behind China amid cuts to science funding

Trending
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

FDA extends review timelines for four priority voucher drugs
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs